Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Invivyd
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Rapid Antibody Advances Will Leverage Secular Pandemic Trends
Key Takeaways Invivyd's COVID-19 and next-generation antibody products are primed for durable, expanding revenue streams, potentially outpacing market expectations through breakthrough clinical benefits and guideline inclusion. The company's diversified pipeline, pandemic readiness focus, and operational efficiency position it for higher growth, stronger margins, and sustained earnings in a shifting healthcare landscape.
View narrative
US$5.00
FV
89.6% undervalued
intrinsic discount
110.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Core Scientific
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Bitcoin Adoption And Renewable Power Will Transform Data Centers
Key Takeaways Core Scientific leverages low-risk, capital-light contracts and first-mover advantages to achieve outsized margins and rapid, recurring revenue growth in AI datacenter markets. Strategic power partnerships and a hybrid business model ensure persistent cost advantages, sustainability, and diversified earnings from both digital asset and compute market expansion.
View narrative
US$23.00
FV
41.1% undervalued
intrinsic discount
71.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Neuren Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Rising Rett Diagnoses Will Expand Orphan And Pediatric Markets
Key Takeaways Rising diagnosis and accelerated international expansion position Neuren for sustained revenue growth and enhanced profit margins ahead of market expectations. Regulatory incentives and expanding patient pools support compounding earnings growth, while disciplined costs and royalty revenue strengthen cash generation and shareholder returns.
View narrative
AU$30.90
FV
44.4% undervalued
intrinsic discount
1.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Geron
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Precision Medicine And Telomerase Inhibition Will Expand Therapeutic Markets
Key Takeaways Rapid uptake of RYTELO, strategic partnerships, and superior commercial execution could drive revenue and market share beyond current expectations. Strong leadership, financial resources, and innovative therapies position Geron for pipeline advancement and long-term value creation in a growing market.
View narrative
US$6.00
FV
75.7% undervalued
intrinsic discount
64.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Root
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Digital Adoption And Telematics Will Redefine Insurance Experiences
Key Takeaways Rapid digital scaling and advanced AI models drive superior growth, margin expansion, and strong competitive positioning versus legacy carriers. Robust capital reserves and exclusive real-time data access fuel ongoing innovation, national expansion, and enhanced long-term profitability.
View narrative
US$165.00
FV
44.8% undervalued
intrinsic discount
18.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Life360
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Tile Integration And Global Smartphone Adoption Will Boost Family Safety
Key Takeaways Rapid global user adoption, ecosystem integration, and shifting consumer attitudes are accelerating recurring revenue, pricing power, and long-term profitability for the company. Unique data assets and a strong balance sheet underpin new high-margin advertising growth and strategic expansion into related technology markets.
View narrative
AU$51.00
FV
11.6% undervalued
intrinsic discount
26.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
V.F
AN
AnalystHighTarget
Consensus Narrative from 20 Analysts
Emerging Asian Trends And Digital Shifts Will Drive Expansion
Key Takeaways Cost transformation, digital-first strategy, and operational agility set the stage for meaningful margin expansion and resilient, higher-quality revenues insulated from wholesale volatility. Global brand strength, innovation in sustainability, and premium brand positioning support outperformance in key markets and core brands, fostering accelerated growth and long-term share gains.
View narrative
US$27.10
FV
49.5% undervalued
intrinsic discount
4.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Five9
AN
AnalystHighTarget
Consensus Narrative from 21 Analysts
Digital Transformation And AI Will Power Omnichannel Expansion
Key Takeaways Accelerating enterprise AI adoption and deepening integration partnerships are set to drive faster revenue growth, margin expansion, and greater pricing power than expected. Shifting to high-margin, software-first models and leveraging compliance strengths position Five9 for outsized profitability, premium pricing, and rapid scale in underpenetrated verticals.
View narrative
US$50.22
FV
45.1% undervalued
intrinsic discount
10.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Alkami Technology
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Plaid Integration And Digital Transformation Will Fuel Open Banking Evolution
Key Takeaways Rapid adoption of integrated MANTL solutions and dual platform strategy enable faster-than-expected revenue growth, expanded client reach, and higher recurring revenue per user. Platform flexibility and open API partnerships position Alkami as a leader in digital transformation for regional banks, supporting sustained market share gains and strong profitability.
View narrative
US$46.00
FV
45.0% undervalued
intrinsic discount
24.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies